Amyotrophic lateral sclerosis (ALS) is a severe and progressive neurological disease that is currently incurable. Available therapies aim at slowing down the disease (neuroprotective therapy) and treating symptoms and disabilities resulting from ALS (symptomatic therapy).
The members of the German ALS/MND-NET are clinical and scientific experts in the diagnosis and treatment of ALS and other motor neuron diseases. In addition to striving to provide a comprehensive treatment approach to all patients, the group’s mission is to explore new therapeutic approaches in clinical trials. As treatment options in ALS are currently very limited, we see a clear need to develop new evidence-based treatments for our patients.